Source: Annual Congress 2006 - Implications of progressive airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Anaev, E. Kuritsyna, A. Karyakin, A. Chuchalin (Moscow, Russian Federation). Exhaled hydrogen peroxide in patients with stable chronic obstructive pulmonary disease: effect of cigarette smoking. Eur Respir J 2006; 28: Suppl. 50, 3665

Member's Comments

No comment yet.

Related content which might interest you: Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD Source: Eur Respir J 2007; 29: 51-55 Year: 2007 Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 439-443 Year: 2003 Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Levels of NO in exhaled air at patients with chronic obstructive pulmonary diseases in high altitude Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in exposed to low-dose radiation Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008 Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010